The global market size for human vaccines is anticipated to observe tremendous growth projections during 2019–2025.
The prominent factors that are expected to contribute to the growth of the global human vaccines market during the forecast period:
- Increased Disease Awareness
- Approval/launches of the New Vaccines
- Rising focus on immunization programs
- Increasing government support for the vaccine development
Highlighted with 35 tables and 140 figures, this 310-page report “Global Human Vaccines Market Size, Trends, Opportunities and Growth Potential” provides a comprehensive analysis of the fast-evolving, high-growth global human vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the global human vaccines market. The report provides historical market data for 2015–2018, and forecasts from 2019 till 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides in-depth analysis, information and revenue according to segments such as disease indications, end-users, leading vaccines, and companies from 2015 to 2018 and forecasts to 2025. A comprehensive analysis has been done on market share with percentage of all the segments.
Global Human Vaccines Market, By Leading Vaccines
- Prevnar / Prevnar 13
- Gardasil / Gardasil 9
- Pneumovax 23
- Priorix, Priorix Tetra, Varilrix
- M–M–R II
- Pentacel, Pentaxim, Imovax, Hexaxim
- Pediarix, Infanrix
- Biken Ha
- Varicella (MTP)
- Jebik V
- Bio Thrax
- In Live
Contact Us: Maria Rai Head of Business Development DPI Research | Web: https://dpiresearch.com Direct Line: +91-766-764-8693 E-mail: [email protected]